69 related articles for article (PubMed ID: 27655598)
1. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
2. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
Clin Chim Acta; 2024 Jun; 560():119732. PubMed ID: 38772522
[TBL] [Abstract][Full Text] [Related]
4. Essential hypertension: A filtered serum based metabolomics study.
Ameta K; Gupta A; Kumar S; Sethi R; Kumar D; Mahdi AA
Sci Rep; 2017 May; 7(1):2153. PubMed ID: 28526818
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
6. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
[TBL] [Abstract][Full Text] [Related]
7. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
8. A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.
Sui W; Li L; Che W; Guimai Z; Chen J; Li W; Dai Y
Clinics (Sao Paulo); 2012; 67(4):363-73. PubMed ID: 22522762
[TBL] [Abstract][Full Text] [Related]
9. Multiomics Analysis Revealed Colorectal Cancer Pathogenesis.
Xu YJ; He Y; Chen C; Shi J; He M; Liu Y; Zhang Y; Liu Y; Zhang Y
J Proteome Res; 2024 Jun; 23(6):2100-2111. PubMed ID: 38634357
[TBL] [Abstract][Full Text] [Related]
10. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.
Okuda Y; Shimura T; Abe Y; Iwasaki H; Nishigaki R; Fukusada S; Sugimura N; Kitagawa M; Yamada T; Taguchi A; Kataoka H
J Gastroenterol; 2024 Jun; ():. PubMed ID: 38836911
[TBL] [Abstract][Full Text] [Related]
11. Untargeted metabolomics in gastric and colorectal cancer patients - preliminary results.
Kaźmierczak-Siedlecka K; Muszyński D; Styburski D; Makarewicz J; Sobocki BK; Ulasiński P; Połom K; Stachowska E; Skonieczna-Żydecka K; Kalinowski L
Front Cell Infect Microbiol; 2024; 14():1394038. PubMed ID: 38774628
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages.
de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer.
Clos-Garcia M; Garcia K; Alonso C; Iruarrizaga-Lejarreta M; D'Amato M; Crespo A; Iglesias A; Cubiella J; Bujanda L; Falcón-Pérez JM
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32370168
[TBL] [Abstract][Full Text] [Related]
14. Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer.
Zhu G; Wang Y; Wang W; Shang F; Pei B; Zhao Y; Kong D; Fan Z
Front Oncol; 2021; 11():729512. PubMed ID: 34804922
[TBL] [Abstract][Full Text] [Related]
15. Identification of microbial markers across populations in early detection of colorectal cancer.
Wu Y; Jiao N; Zhu R; Zhang Y; Wu D; Wang AJ; Fang S; Tao L; Li Y; Cheng S; He X; Lan P; Tian C; Liu NN; Zhu L
Nat Commun; 2021 May; 12(1):3063. PubMed ID: 34031391
[TBL] [Abstract][Full Text] [Related]
16. Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Richard V; Conotte R; Mayne D; Colet JM
Oncotarget; 2017 Jul; 8(30):49915-49930. PubMed ID: 28611296
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia.
Montrose DC; Zhou XK; Kopelovich L; Yantiss RK; Karoly ED; Subbaramaiah K; Dannenberg AJ
Cancer Prev Res (Phila); 2012 Dec; 5(12):1358-67. PubMed ID: 22961778
[TBL] [Abstract][Full Text] [Related]
18. Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis.
Altobelli E; Angeletti PM; Latella G
J Cancer; 2016; 7(14):1984-2004. PubMed ID: 27877214
[TBL] [Abstract][Full Text] [Related]
19. Distinctive Lipid Characteristics of Colorectal Cancer Revealed through Non-targeted Lipidomics Analysis of Tongue Coating.
Chen Q; Lin F; Li W; Gu X; Chen Y; Su H; Zhang L; Zheng W; Zeng X; Lu X; Wang C; Chen W; Zhang B; Zhang H; Gong M
J Proteome Res; 2024 Jun; 23(6):2054-2066. PubMed ID: 38775738
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies.
Loftfield E; Vogtmann E; Sampson JN; Moore SC; Nelson H; Knight R; Chia N; Sinha R
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1483-1490. PubMed ID: 27543620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
